.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Harvard Business School
Chinese Patent Office
Merck
Moodys
Deloitte
Healthtrust
Fish and Richardson
Johnson and Johnson

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020767

« Back to Dashboard

NDA 020767 describes PROPULSID QUICKSOLV, which is a drug marketed by Janssen Pharma and is included in one NDA. Additional details are available on the PROPULSID QUICKSOLV profile page.

The generic ingredient in PROPULSID QUICKSOLV is cisapride monohydrate. There are two drug master file entries for this compound. Additional details are available on the cisapride monohydrate profile page.

Summary for 020767

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Medical Subject Heading (MeSH) Categories for 020767

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, ORALLY DISINTEGRATING;ORALStrengthEQ 20MG BASE
Approval Date:Nov 7, 1997TE:RLD:No

Expired Orange Book Patents for NDA: 020767

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen PharmaPROPULSID QUICKSOLVcisapride monohydrateTABLET, ORALLY DISINTEGRATING;ORAL020767-001Nov 7, 1997► Subscribe► Subscribe
Janssen PharmaPROPULSID QUICKSOLVcisapride monohydrateTABLET, ORALLY DISINTEGRATING;ORAL020767-001Nov 7, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Colorcon
Citi
McKesson
US Department of Justice
Merck
Cerilliant
QuintilesIMS
Accenture
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot